Vigilare Wealth Management Sells 100 Shares of Danaher Co. (NYSE:DHR)

Vigilare Wealth Management lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 5.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,898 shares of the conglomerate’s stock after selling 100 shares during the quarter. Vigilare Wealth Management’s holdings in Danaher were worth $456,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. GPS Wealth Strategies Group LLC acquired a new stake in Danaher during the 1st quarter worth $25,000. Freedom Wealth Alliance LLC bought a new stake in shares of Danaher in the fourth quarter valued at about $27,000. Chelsea Counsel Co. bought a new stake in shares of Danaher in the fourth quarter valued at about $27,000. Silicon Valley Capital Partners bought a new stake in shares of Danaher in the first quarter valued at about $29,000. Finally, Stone House Investment Management LLC bought a new stake in shares of Danaher in the first quarter valued at about $32,000. Institutional investors and hedge funds own 76.71% of the company’s stock.

Danaher Stock Performance

NYSE DHR traded up $1.77 during trading on Friday, reaching $255.25. 5,696,631 shares of the company’s stock were exchanged, compared to its average volume of 2,877,042. The business has a 50 day moving average price of $253.41 and a 200-day moving average price of $245.09. The stock has a market capitalization of $188.46 billion, a P/E ratio of 29.96, a PEG ratio of 2.72 and a beta of 0.80. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.08 and a quick ratio of 1.70. Danaher Co. has a fifty-two week low of $221.22 and a fifty-two week high of $283.63.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 25th. The conglomerate reported $2.05 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.04. The firm had revenue of $7.16 billion for the quarter, compared to the consensus estimate of $7.12 billion. Danaher had a return on equity of 15.03% and a net margin of 20.95%. The business’s revenue was down 7.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.76 earnings per share. Sell-side analysts forecast that Danaher Co. will post 8.84 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Thursday, October 12th will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a dividend yield of 0.42%. The ex-dividend date of this dividend is Wednesday, October 11th. Danaher’s payout ratio is 12.68%.

Wall Street Analyst Weigh In

A number of analysts have recently commented on the company. Barclays boosted their price target on Danaher from $260.00 to $290.00 and gave the company an “overweight” rating in a report on Tuesday, July 25th. Raymond James boosted their price target on Danaher from $270.00 to $290.00 and gave the company an “outperform” rating in a report on Wednesday, July 26th. Stifel Nicolaus cut their price target on Danaher from $250.00 to $240.00 and set a “hold” rating on the stock in a report on Wednesday, July 26th. Royal Bank of Canada boosted their price target on Danaher from $260.00 to $292.00 in a report on Wednesday, July 26th. Finally, StockNews.com began coverage on Danaher in a report on Tuesday, September 12th. They set a “hold” rating on the stock. Five research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $289.79.

Insider Activity

In other news, EVP Joakim Weidemanis sold 22,439 shares of the company’s stock in a transaction that occurred on Wednesday, July 26th. The stock was sold at an average price of $263.42, for a total value of $5,910,881.38. Following the transaction, the executive vice president now owns 88,689 shares of the company’s stock, valued at $23,362,456.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Teri List sold 3,490 shares of the company’s stock in a transaction that occurred on Wednesday, July 26th. The stock was sold at an average price of $263.30, for a total value of $918,917.00. Following the transaction, the director now owns 17,494 shares of the company’s stock, valued at $4,606,170.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Joakim Weidemanis sold 22,439 shares of the company’s stock in a transaction that occurred on Wednesday, July 26th. The shares were sold at an average price of $263.42, for a total value of $5,910,881.38. Following the completion of the transaction, the executive vice president now directly owns 88,689 shares in the company, valued at approximately $23,362,456.38. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,922 shares of company stock valued at $12,552,233. 11.10% of the stock is owned by insiders.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes and services; and healthcare filtration solutions.